open access

Vol 6, No 1 (2001)
Untitled
Published online: 2001-01-01
Submitted:
Get Citation

56. The role of external irradiation in postoperative treatment of soft tissue sarcomas – last decade of gliwice experience

W. Sąsiadek, B. Pilecki, M. Syguła, M. Goleń, W. Przeorek, A. Mucha, A. Wygoda, K. Składowski
DOI: 10.1016/S1507-1367(01)70426-9
·
Rep Pract Oncol Radiother 2001;6(1):53.

open access

Vol 6, No 1 (2001)
Untitled
Published online: 2001-01-01
Submitted:

Abstract

Aim of the study was to evaluate the role of postoperative external irradiation in the treatment of patients with high risk of local relapse of soft tissue sarcomas, as well as to evaluate the long-term results of this combined treatment. Data charts of the 77 patients with STS treated by surgery and postoperative external beam radiotherapy in Institute of Oncology in Gliwice during the period 1990–1999 has been reviewed. Extremity was the most frequent tumour site (75%), followed by trunk (10%), pelvis (7%), head and neck (4%) and retroperitoneal space (4%). Histological types included liposarcoma (27%), MFH (23%), fibrosarcoma (22%), neurosarcoma (12%), synovial sarcoma (8%) and others (8%). Only in 52% of patients the grade of the tumour was evaluated (G1–12 pts, G2–14 pts, G3–14 pts). Only 23 patients (30%) was treated by chemotherapy after local treatment. In majority patients were primary operated at general surgery departments, outside the reference centre with technique typical for benign tumours. Because of non-radical first surgical treatment and large number of early local recurrences in a whole group over 140 operations has been undertaken. Surgical margins were proven by histological procedures only in 29% of the patients. Long term OS, DFS and LC rates have been 64%, 56% and 69% respectively. Distant metastases have occurred in 30% of pts. during the first 2 years of observation. Prognostic factors have been evaluated in both univariate and multivariate analysis. The most important positive prognostic factors were as follows: radical surgical treatment and concomitant chemo-radiotherapy.

The first, often proven or suspected as non-radical, tumour excision is the most important and probably independent negative prognostic factor for tumour cure and patient survival. For such clinical situations secondary surgical approach as a wide excision is recommended. Because of a large number of cases in analysed material with single or multiple local relapses decision of adjuvant therapy has to be considered individually. It seems that in such clinical situation, postoperative radiotherapy or aggressive radio-chemotherapy in cases with no clinically detected local relapse gives the best chance for survival. The long time of anamnesis, several surgical treatments of tumour relapses with no sarcoma policy stress the need to establish the general national rules for diagnosis and adjuvant treatment of soft tissue sarcomas.

Abstract

Aim of the study was to evaluate the role of postoperative external irradiation in the treatment of patients with high risk of local relapse of soft tissue sarcomas, as well as to evaluate the long-term results of this combined treatment. Data charts of the 77 patients with STS treated by surgery and postoperative external beam radiotherapy in Institute of Oncology in Gliwice during the period 1990–1999 has been reviewed. Extremity was the most frequent tumour site (75%), followed by trunk (10%), pelvis (7%), head and neck (4%) and retroperitoneal space (4%). Histological types included liposarcoma (27%), MFH (23%), fibrosarcoma (22%), neurosarcoma (12%), synovial sarcoma (8%) and others (8%). Only in 52% of patients the grade of the tumour was evaluated (G1–12 pts, G2–14 pts, G3–14 pts). Only 23 patients (30%) was treated by chemotherapy after local treatment. In majority patients were primary operated at general surgery departments, outside the reference centre with technique typical for benign tumours. Because of non-radical first surgical treatment and large number of early local recurrences in a whole group over 140 operations has been undertaken. Surgical margins were proven by histological procedures only in 29% of the patients. Long term OS, DFS and LC rates have been 64%, 56% and 69% respectively. Distant metastases have occurred in 30% of pts. during the first 2 years of observation. Prognostic factors have been evaluated in both univariate and multivariate analysis. The most important positive prognostic factors were as follows: radical surgical treatment and concomitant chemo-radiotherapy.

The first, often proven or suspected as non-radical, tumour excision is the most important and probably independent negative prognostic factor for tumour cure and patient survival. For such clinical situations secondary surgical approach as a wide excision is recommended. Because of a large number of cases in analysed material with single or multiple local relapses decision of adjuvant therapy has to be considered individually. It seems that in such clinical situation, postoperative radiotherapy or aggressive radio-chemotherapy in cases with no clinically detected local relapse gives the best chance for survival. The long time of anamnesis, several surgical treatments of tumour relapses with no sarcoma policy stress the need to establish the general national rules for diagnosis and adjuvant treatment of soft tissue sarcomas.

Get Citation
About this article
Title

56. The role of external irradiation in postoperative treatment of soft tissue sarcomas – last decade of gliwice experience

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 6, No 1 (2001)

Pages

53

Published online

2001-01-01

DOI

10.1016/S1507-1367(01)70426-9

Bibliographic record

Rep Pract Oncol Radiother 2001;6(1):53.

Authors

W. Sąsiadek
B. Pilecki
M. Syguła
M. Goleń
W. Przeorek
A. Mucha
A. Wygoda
K. Składowski

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl